Related by context. All words. (Click for frequent words.) 89 Announces Licensing Agreement 87 Announce License Agreement 87 Signs License Agreement 87 Signs Licensing Agreement 83 Enters Into Licensing Agreement 83 Sign License Agreement 82 Announce Licensing Agreement 82 Enters Into License Agreement 80 Enters Agreement 80 Sign Licensing Agreement 80 Begins Shipment 80 Announce Merger Agreement 80 Enters Into Agreement 80 Expands Portfolio 80 Announces Immediate Availability 79 Announce Collaboration 79 Completes Merger With 79 Files Patent Application 79 Completes Merger 79 Receives Patent 79 Signs Reseller Agreement 79 Signs Merger Agreement 79 Amends Agreement 79 Enters Into Strategic 79 Renews Agreement 79 Announce Collaboration Agreement 79 Enters Strategic 79 Inks Pact 78 Initiates Enrollment 78 Files Shelf Registration Statement 78 Expand Relationship 78 Signs Distribution 78 Completes Patient Enrollment 78 Stockholders Approve Merger 78 Files IND 78 Enters Into Exclusive 78 Awarded Patent 78 Finalizes Acquisition 78 Announces Definitive Agreement 78 Announces FDA Clearance 78 Settles Patent Dispute 78 Inks Licensing Deal 78 Completes Reverse Merger 78 Licenses Novel 77 Inks Distribution 77 Settle Patent Litigation 77 Announces Termination 77 Subsidiary Enters 77 Successfully Completes Tender Offer 77 Expands Relationship 77 Taglich Brothers Initiates Coverage 77 Initiates Clinical Trial 77 Expands Internationally 77 Acquires Exclusive 77 Extends Relationship 77 Shareholders Approve Merger Agreement 77 Unveils Innovative 77 Restructures Operations 77 Receives Orphan Drug Designation 77 Signs Agreements 77 Announces Reseller Agreement 77 Forms Strategic 77 Settles Litigation 77 Completes Tender Offer 77 Receives Approvable Letter 77 Announce Definitive Agreement 77 Launches Next Generation 77 Strengthens Position 77 Initiates Phase II 77 Successfully Completes Acquisition 77 Announces Additions 77 Closes Merger 77 Introduces Next Generation 77 Q3 Loss Narrows 77 Secures Additional 77 Extends Collaboration 77 Begins Shipping 76 Announces Organizational Changes 76 Settles Patent Litigation 76 Signs Licensing 76 Introduces Innovative 76 Q2 Loss Narrows 76 Introduces Enhanced 76 Sinks Lower 76 Forges Partnership 76 Achieves ISO #:# Certification [002] 76 Terminates Agreement 76 Welcomes Analyst Initiation 76 Completes Enrollment 76 Enrolls First 76 Announces Initiation 76 Announces Early Termination 76 Introduces Revolutionary 76 Receives Milestone Payment 76 PRODUCT SOURCE 76 Expands Relationship With 76 Announces Signing 76 Completes Financing 76 Regains Compliance 76 Finalizes Purchase 76 Streamlines Operations 76 Collaborates With 76 Renews Relationship 76 Signs Exclusive 76 Achieves Milestone 76 Obtains License 76 Commercializes 76 Announces Favorable 76 Renews Partnership 76 CONFERENCE CALLS SOURCE 76 Earnings Postmortem 76 Strengthens Its 76 Q1 Loss Narrows 76 Extend Partnership 76 Releases Next Generation 76 Shareholders Approve Merger 76 Terminates Contract 76 Expand Collaboration 75 Jumps Higher 75 Executes Agreement 75 Files Patent 75 Secures Funding 75 Announce Availability 75 FDA Clears 75 Unveils Latest 75 Submits Application 75 Signs Agreement 75 Secures Financing 75 Shareholders Approve Acquisition 75 Regains Compliance With 75 Extend Relationship 75 Introduces Breakthrough 75 Announce Agreement 75 Announces Enhancements 75 Signs Definitive Agreement 75 Appoints Seasoned 75 Q1 Loss Widens 75 Licensing Deal 75 Acquire Assets 75 Announces Successful Completion 75 Inks Deal With 75 Initiates Clinical Trials 75 Initiates Dosing 75 Presents Preclinical Data 75 Unveils Revolutionary 75 Q3 Loss Widens 75 Q2 Loss Widens 75 Enters Joint Venture 75 Discontinues 75 Enters Into Joint Venture 75 Expands Capabilities 75 Delivers Next Generation 75 Inks Deal 75 Gets FDA Clearance 75 Complete Merger 75 Acquires Assets 75 Q4 Loss Narrows 75 Launches Unique 75 Guides Inline 75 Strengthens Leadership 75 Exploring Strategic Alternatives 74 Buys Majority Stake 74 Mutually Agree 74 Completes Recapitalization 74 Terminate Merger Agreement 74 Finalizes Agreement 74 Launches Redesigned Website 74 Unveils Newest 74 Enters Into Definitive Agreement 74 Inks Licensing Agreement 74 Receives Certification 74 Unveils Next Generation 74 Awarded Patents 74 Board Authorizes 74 Strengthens Balance Sheet 74 Confirms Commitment 74 Announce Exclusive 74 Completes Acquisitions 74 Announce Reseller Agreement 74 NewsBite Downgrade Puts Pressure 74 Therapeutic Competitors Companies 74 Receives FDA Clearance 74 Receives NASDAQ 74 Announces Stockholder Approval 74 Receives SFDA Approval 74 Explore Strategic Alternatives 74 Broadens Its 74 Announces Divestiture 74 CONFERENCE CALLS EARNINGS SOURCE 74 Enters Oversold Territory 74 Forges Strategic 74 Thewallstreetleader.com Profiles 74 Announces Expanded 74 Successfully Closes 74 Ink Deal 74 Achieves Record Sales 74 Awarded Multi 74 Inks Agreement 74 Announce Joint Venture 74 Announces Publication 74 Extend Collaboration 74 Rated Speculative Buy 74 Obtains Exclusive License 74 Strengthens Relationship 74 Stockholders Approve Acquisition 74 Releases Enhanced 74 Patent Issued 74 Restructures Debt 74 MANAGEMENT CHANGES SOURCE 74 Attracting Bullish Investors 74 Appoints Experienced 74 Announce Early Termination 74 Extends Reach 74 Settle Patent Dispute 74 Announces Issuance 74 Develop Next Generation 74 Distribution Pact 74 Announce Interoperability 74 Signs Joint Venture 74 Announces Formation 74 Licenses Patents 74 Receives Tentative Approval 74 Initiates Clinical 74 Introduces Powerful 74 Announces Shareholder Approval 74 Extends Tender Offer 74 Launches Expanded 73 Expands Distribution 73 DayTradersDigest.com Profiles 73 Sign Reseller Agreement 73 Signs Long Term 73 Other OTC MNDP 73 Announce Licensing 73 Secures Contract 73 Announces Sponsorship 73 Further Strengthens 73 Debuts Next Generation 73 Present Preclinical Data 73 Enter Into 73 Acquires Controlling Interest 73 Receives Favorable 73 Announces Departure 73 Q4 Loss Widens 73 Retains CCG Investor Relations 73 Announces Addition 73 Submits Biologics License Application 73 MARKETING AGREEMENTS PRODUCT SOURCE 73 Enhances User Experience 73 Terminates Merger Agreement 73 Provides Update Regarding 73 Closes Acquisition 73 Completes Purchase Of 73 Significantly Enhances 73 Awarded GSA Schedule 73 Completes Transaction 73 AUDIO PROVIDED BY 73 * vwd PRN 73 Enters Exclusive 73 Announce Completion 73 Expands Scientific Advisory 73 AllPennyStocks.com Spotlights 73 Reports Receipt 73 Announces Effective Date 73 Post Earnings Checkup 73 Evaluate Strategic Alternatives 73 Completes Integration 73 MONSTERSTOX.COM Monsterstox.com 73 Announce Partnership 73 Announces Acquisition 73 Achieves Significant 73 Signs Lease 73 Acquirer Company 73 SWOT Analysis Aarkstore Enterprise 73 PROFILE CO 73 Closes Acquisition Of 73 Files Patents 73 Unveils Groundbreaking 73 Attains Gold Certified Partner 73 Completes Transition 73 Director Exercises Options 73 Strengthens Commitment 73 Aquires 73 Files Registration Statement 73 Expands Offerings 73 Enters Into Partnership 73 Settles Patent Suit 73 Buy Privately Held 73 Reports Profitable 73 Extends Capabilities 73 Endures Analyst Downgrade 73 Subsidiary Acquires 73 Provides Shareholder 73 Stockholders Approve Merger Agreement 73 Inks License 73 Completes Purchase 73 Unveils Expanded 73 Signs Purchase Agreement 73 Joins Forces 73 Signs Definitive Merger Agreement 73 Jointly Announce 73 Restate Financials 73 BioSante Pharmaceuticals Announces 73 Expands Scope 73 Announce Strategic 73 Introduces Expanded 73 Launches Innovative 73 Launches Enhanced 73 Signs Pact 73 Receives CE Marking 73 Bearish MACD 73 Subsidiary Signs 73 Flagship Product 73 Exercises Option 73 Achieves Certification 73 Q2 Adj 73 Attains 72 Bearish Speculation 72 Launches Groundbreaking 72 Completes Asset 72 Obtains Approval 72 Receives Notification 72 Announces Discontinuation 72 Net Loss Widens 72 Signs Definitive 72 Board Unanimously Rejects 72 CFO Exercises Options 72 Presents Positive 72 Forms Joint Venture 72 Unveils Breakthrough 72 Introduces Groundbreaking 72 Improves Efficiency 72 Consummates 72 Develops Innovative 72 Named Exclusive Distributor 72 Changes Ticker Symbol 72 Successfully Concludes 72 AGREEMENTS SOURCE 72 Begins Dosing 72 Completes Acquisition 72 Explores Strategic Alternatives 72 Receives Clearance 72 WeissComm Partners +#-#-#-# 72 Extends Expiration Date 72 Therapeutic Competitors Report 72 Unveils Powerful 72 TRADESHOW SOURCE 72 Announces Tentative Approval 72 Voluntarily Withdraw 72 Confirms Receipt 72 Completes Reorganization 72 MARKETING AGREEMENTS SOURCE 72 CybeRelease Decliners 72 Enters Into Merger Agreement 72 Movers Roundup 72 CFO Resigns 72 Completes Buyout 72 Lowers Guidance 72 Net Loss Narrows 72 Ups Guidance 72 http:/www.Send2Press.com SOURCE 72 Expands Availability 72 INDICATED LOWER 72 Deliver Presentation 72 Motorola Invests 72 Announces Rebranding 72 Joins Hands 72 Updates Guidance 72 Reduces Debt 72 Announces Cancellation 72 Expands Globally 72 Receives Unsolicited 72 Announces Recapitalization 72 Completes Refinancing 72 Secures Patent 72 Delivers Breakthrough 72 Unveils Enhanced 72 Achieves SAS 72 Enters Into Collaboration 72 Completes Restructuring 72 Showcases Innovative 72 Signs MOU 72 Develop Novel 72 Completes Successful 72 Regains Full 72 Completes Installation 72 SVP Exercises Options 72 Announces Expansion 72 Rebrands 72 Signs Multi 72 Announce Settlement 72 Expands Presence 72 Acquires Majority 72 Finalizes Merger 72 Submits NDA 72 Inks Deals 72 Furthers 72 Officially Launches 72 Reports Preclinical Data 72 Significantly Reduces 72 News Unternehmensnachrichten 72 Closes Sale 71 Ventures Invests 71 Enters Definitive Agreement 71 BIOTECHNOLOGY SOURCE 71 Announces Postponement 71 Expands Deployment 71 Extends Contract 71 Inks Exclusive 71 Enters Into 71 Inc.today announced 71 Q3 Adj 71 CEO Exercises Options 71 Receives Orphan Drug 71 Stock Downgraded 71 Reaches Settlement Agreement 71 DARA logo 71 Settles Patent Lawsuit 71 Settles Dispute 71 Awarded Qualifying Therapeutic 71 Awarded Contract Extension 71 VP Exercises Options 71 Spins Off 71 Announce Expanded 71 Submits IND 71 researches develops licenses 71 Settle Litigation 71 Nasdaq XTLB 71 Expands Into 71 F#Q# Qtr End 71 Receives Commitment 71 Commences Tender Offer 71 Signs Contract 71 Amend Merger Agreement 71 Subsidiary Enters Into 71 Increases Ownership 71 Closes Financing 71 Announces Underwriters Exercise 71 COO Exercises Options 71 Expands Capacity 71 Receives Recognition 71 OTC BB NECO 71 Reach Settlement Agreement 71 Annouces 71 INDICATED HIGHER 71 Reveals Positive 71 Q1 Profit Decreases 71 Completes Divestiture 71 Earns Certification 71 Commercialize 71 Inc. OTCBB MNDP 71 Receives Notice Regarding 71 Initiates Phase III 71 Announces Adjournment 71 Licensing Pact 71 Introduces Affordable 71 Acquires Remaining Interest 71 Celebrates Opening 71 Breakthroughstocks.net EXPLOSIVE news 71 Q4 Profit Surges 71 Acquire Controlling Interest 71 Continues Expansion 71 Posts Narrower Loss 71 Outlines Strategy 71 Extends Commitment 71 Receives Favorable Ruling 71 Ink Pact 71 Extends Relationship With 71 Signs LOI 71 Provides Preliminary 71 Receives Funding 71 Reacquires 71 Files Annual Report 71 Revolutionizes 71 Provide Comprehensive 71 Receives Notice From 71 Expands Commitment 71 Calls Purchased 71 Signs Non Binding 71 Regains NASDAQ 71 Unveils Latest Version 71 :/ finance.yahoo.com q 71 Shows Promise 71 Demonstrates Significant 71 Delivers Enhanced 71 Announces Intent 71 Retains Leading 71 NASDAQ. 71 Autodesk Completes Acquisition 71 Reaches Agreement 71 Signs Deal 71 Continues Momentum 71 Finalizes Contract 71 Upside Looming 71 Announce Expiration 71 Announces Commencement 71 Adopts Stockholder Rights 71 Reports Inducement Grants 71 R MSCRAMM 71 TheWallStreetLeader.com Profiles 71 Enters Into Definitive 71 Files Patent Infringement 71 Bullish Speculation 71 Announces Receipt 71 Receives ISO #:# [001] 71 Acquire Privately Held 71 Revitalizes 71 Achieves ISO # 71 Moving Average Crossover Alert 71 Posts Wider Loss 71 Spins Out 71 Files Shelf Registration 71 Introduces Novel 71 Establishes Strategic 71 Commences Cash 71 Relaunches 71 Unwraps 71 Demonstrates Interoperability 71 Announces Presentation 71 Authorizes Additional 71 Announce Formation 71 Q1 Adj 70 Shares Plunged What 70 Restructures 70 #.#.# Meldung [001] 70 Earns Milestone Payment 70 Releases Latest Version 70 Continues Aggressive 70 Extends Leadership 70 Provides Updates 70 Stock Upgraded 70 TM Aganocide 70 Starts Shipping 70 Bearish Pressure Building 70 Expands Functionality 70 License Pact 70 Formalizes 70 Closes Previously Announced 70 COMUNICADO DE 70 Canaccord Genuity Maintains Hold 70 Announces Dismissal 70 Presents Positive Preclinical 70 www.shamrockstocks.com About 70 CRWESelect CRWESelect.com Highlights 70 Achieves Record 70 Inc Therapeutic Competitors 70 Finalizes Sale 70 Announce Merger 70 Bullish Technical Alert 70 COMUNICADO 70 Celebrates Tenth Anniversary 70 Successfully Completes 70 TSX Delisting Review 70 Enters Into Letter 70 Ships #th 70 Novartis Novo Nordisk 70 otcstockexchange.com 70 Given Outperform Rating 70 Retains Investor Relations 70 Receives Notice 70 Completes Initial 70 Relocates Corporate Headquarters 70 Updates Shareholders 70 Commences Phase 70 Posts Strong 70 Achieves Record Revenue 70 MERGERS ACQ SOURCE 70 Approve Merger 70 Wins Patent Infringement 70 Holds Annual Meeting 70 Announces Definitive Agreements 70 Changes Name 70 Purchases Moore Microprocessor 70 3M Completes Acquisition 70 EVP Exercises Options 70 Successfully Integrates 70 Posts Wider 70 CRWEWallstreet.com Stock Report 70 Finalize Agreement 70 Completes Expansion 70 Q4 Profit Plunges 70 Receives Approval 70 Bullish Average Crossover 70 Achieves Record Growth 70 Bearish Average Crossover 70 Accelerates Growth 70 Signs Option Agreement 70 Shareholders Approve Sale 70 Introduces Unique 70 Receives Coveted 70 Shares Popped What 70 Aligns 70 PRN4 70 ADVISORY CONFERENCE CALLS SOURCE 70 Introduce Next Generation 70 Proudly Announces 70 Reports Positive 70 Demonstrates Commitment 70 HSR Waiting Period 70 Announces Proposed Acquisition 70 Puts Purchased 70 Beats Raises Guidance 70 Q4 Profit Climbs 70 Delivers Comprehensive 70 Subsidiary Receives 70 Concludes Successful 70 CEO Discusses F#Q# [001] 70 Releases Upgraded 70 Announces Affiliation 70 Completes Previously Announced 70 Winning Streak Continues 70 Q3 Profit Surges 70 Enters Into Agreements 70 Latest Addition 70 Sign Definitive Merger 70 Q3 Profit Soars 70 visit http:/www.mannkindcorp.com 70 Forges Alliance 70 Demonstrates Innovative 70 TRANSDUR ™ 70 Announces Launch 70 OTCStockExchange.com Stock Alert 70 Issued Patent 70 Hires Experienced 70 Q2 Profit Surges 70 Updates Status 70 Enters Into Settlement Agreement 70 Achieves ISO 70 Inc. Nasdaq OXGN 70 Reschedules Fourth Quarter 70 Announces Consummation 70 Earnings Scorecard 70 FY# Loss Widens 70 Significantly Expands 70 Acquires Majority Stake 70 Becomes Exclusive 70 Hold Fourth Quarter 70 Receive Milestone Payment 70 Joins OTCQX 70 Meets Primary Endpoint 70 Celebrates Successful 70 CALLS SOURCE 70 Releases Latest 70 Acacia Subsidiary Enters 70 Canaccord Genuity Reiterates Buy 70 Dramatically Expands 70 Celebrates Decade 70 IG HCR ;) CO 70 Introduces Newest 70 Successfully Deploys 70 Wins Summary Judgment 70 Puts Sold 70 Significantly Increases 70 Terminate Agreement 70 Announces Revised 70 Announces Completion 70 Announce Receipt 70 Collaborates 70 Doubles Size 70 Awarded GSA 70 Closes Buyout 70 Q1 Profit Surges 70 Receives Regulatory 70 Relaunches Website 70 Submits Response 70 Announces Poster Presentations 70 Unveils Upgraded 70 Significantly Improves 70 Options Trader Alert 70 Jointly Develop 70 Equipment Deals 70 Therapeutic Competitors companiesandmarkets.com adEgemonye 70 Inks Contract 69 Completes Private Placement 69 Conference Call TRANSCRIPT 69 Renews Contract 69 Enters Into Long Term 69 Maintains Hold Rating 69 Receives Fast Track 69 OTCBB SLAT 69 Announces Availability 69 Realigns 69 Demonstrates Next Generation 69 Receives Stockholder Approval 69 Enters Into Distribution 69 ADDING MULTIMEDIA 69 Beats Analyst 69 Acquires 69 Guides Below 69 Lowest Operating Margin 69 Named Cool Vendor 69 Provides Updated 69 Investigates Proposed Acquisition 69 Announce Initiation 69 Momentum Continues 69 Increases Size 69 Reaches Definitive Agreement 69 PRNewsFoto 69 Establishes Joint Venture 69 Revises Guidance 69 Accepted Into 69 premium True Religion 69 Narrows Guidance 69 Expert Joins 69 Finalize Joint Venture 69 Enters Negotiations 69 2Q Loss Widens 69 Refocuses 69 Selects Camstar 69 Maintains Buy Rating 69 Announces Stock Repurchase 69 Stockholders Approve 69 Makes Bearish 69 Stays Neutral 69 Receives Confirmation 69 Wolf Haldenstein Investigating 69 Daytradersdigest.com 69 Sharpens Focus 69 Drug Candidate 69 Sanofi Aventis Schering Plough 69 Present Webinar 69 PRN8 69 Host Fourth Quarter 69 Announces Reverse Merger 69 Successfully Launches 69 Manufacturer Selects 69 Announces Preliminary 69 Announces Stock Buyback 69 Voluntarily Withdraws 69 AP PhotoExpress Network 69 Initiates Phase 2b 69 platform HDL Mimetic 69 Extends Maturity 69 Showcases Latest 69 Secures Long Term 69 Signs Letter 69 Demonstrate Latest 69 Software Simplifies 69 FY# Loss Narrows 69 Files Definitive Proxy 69 Receives Delisting Notice 69 Regains Nasdaq 69 Helps Clients 69 Q1 Profit Soars 69 Broadens Product 69 Initiates Phase 69 Obtains Patent 69 Q2 Profit Soars 69 Expands Reach 69 Offers Enhanced 69 dedicated CHAT ROOM 69 Initiates Voluntary Recall 69 Namenda Memantine HCl 69 Achieves Prestigious 69 Provides Guidance 69 Trims Loss 69 Scoops Up 69 Reversal Soon 69 COMPLETES ACQUISITION OF 69 Directors Authorizes 69 Achieves Milestones 69 Announces Successful 69 Directors Elects 69 Slashes Price 69 PRN2 69 Sign Definitive Agreement 69 Makes Splash 69 Ramps Up Production 69 Maintains Strong 69 Assets Acquirer Company 69 FREMONT CA #/#/# 69 Inks Multi 69 Named Fastest Growing 69 Platform Enables 69 CysDisplay R 69 First Patient Treated 69 Exec Exercises Options 69 Gets Bearish Confirmation 69 Fortifies 69 Establish Joint Venture 69 Adopts Shareholder Rights 69 Welcomes Analyst 69 Announces Closing 69 Completes Conversion 69 Completes Sale Of 69 Receives Positive 69 Beats Estimates Analyst Blog 69 Resigns Quick Facts 69 Crofelemer budesonide foam 69 Develops Breakthrough 69 PRN3 69 Reaffirms Commitment 69 Files Patent Infringement Lawsuit 69 Achieves ISO #:# Certification [001] 69 Vaccine Adjuvant 69 Awarded Prestigious 69 Successfully Installs 69 BANKING SOURCE 69 Earns Certified Partner 69 SALES RATIO 69 Announces Refinancing 69 Engages Investor Relations 69 Q4 Profit Soars 69 Receives ISO #:# [002] 69 Canaccord Genuity Maintains Buy 69 Schedules Investor 69 Reports Significantly Improved 69 Completes Redemption 69 Announces Latest Version 69 OTCBB VSPC 69 3Q Loss Widens 69 Deliver Powerful 69 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 69 Receives Authorization 69 Oral Suspension USP 69 Q2 Profit Plunges 69 Receives Shareholder Approval 69 Announces Positive 69 Inks MOU 69 Begins Tender Offer 69 Completes Debt Refinancing 69 Unsolicited Proposal From 69 Delivers Powerful 69 Signs Definitive Deal 69 KEYWORD PHARMACEUTICAL 69 Pharma Merck Serono 69 Completes Dosing 69 Becomes Newest 69 OTCBB GNTA 69 Monetizes 69 Q1 Profit Plunges 69 4Q Profit Doubles 69 Finalizes Joint Venture 69 Technicals Showing Bullish 69 Q3 Profit Decreases 69 Sets Quarterly Dividend 69 Announces Definitive Merger 69 Reminds Shareholders 69 Q2 Profit Slips 68 Announces Voluntary Recall 68 Announces Spin Off 68 Reduces Costs 68 Genentech sanofi aventis 68 Enters Into Negotiations 68 FDA Approves 68 Jointly Offer 68 Exclusive License 68 Continues Winning Streak 68 Unveils Enhancements 68 -Pahuta 68 OTCBB NPHC 68 Headquarters Address 68 ELADUR TM 68 Receives Anticipated 68 Guides FY# Quick Facts 68 Demonstrate Innovative 68 Q2 Profit Declines 68 Broadens Scope 68 Successfully Completes Phase 68 Completes Sale 68 Obtains Exclusive Rights 68 www.otc advisors.com names 68 Announces Non Brokered 68 Delivers Unprecedented 68 Daytradersdigest.com Profiles 68 Continues Commitment 68 Aradigm Logo 68 Announces Appointments 68 Announces Proposed 68 Earns Prestigious 68 Wins Contract 68 TheNewsWire Gainers 68 Amplifies 68 RealPennies.com RealPennies.com 68 Q4 Profit Declines 68 EARNINGS SOURCE 68 Deloitte commends 68 Wins Approval 68 Amends Credit 68 Announces 68 Patent Infringement Suit Against 68 Q2 Profit Rises 68 Host Webcast 68 Hold Third Quarter 68 Declares Dividend Quick Facts 68 Increases Productivity 68 Renews Sponsorship 68 Achieves Positive 68 Builds Momentum 68 Repositions 68 Concludes Acquisition 68 Expands 68 Jointly Launch 68 +#-#-#-# Ext [001] 68 Technicals Showing Bearish 68 Put Volume Surges 68 Initiate Clinical Trial 68 Reveals Receipt 68 Receives Positive Rating 68 Expands Footprint 68 Receives Deficiency Letter 68 Reconfirms 68 Teledyne Acquires 68 Closes Private Placement 68 Posts Quarterly 68 Reaffirms Outlook 68 Webcast Annual Meeting 68 Remains Neutral 68 Magazine Recognizes 68 Achieves Profitability 68 Relocate Headquarters 68 Receives Prestigious 68 BayStreet.ca Research Alert 68 Supercharges 68 Amends Merger Agreement 68 Receives Notification From 68 Nasdaq SMTS develops manufactures 68 OTCBB HNAB 68 Announces Share Repurchase 68 Announces Filing 68 Milestone Payment 68 ADVERTISING MARKETING 68 HuCAL PLATINUM R 68 Receives Conditional 68 Exec Joins 68 Signs Memorandum 68 Launches Generic Version 68 IIROC Halt 68 Successfully Completed 68 TRANSDUR ® 68 Posts 4Q 68 Relocates Headquarters 68 Boosts Productivity 68 OTCBB FCSC 68 Announces Ticker Symbol 68 CONTINUES UP 68 Commences Trading 68 Veronate R 68 Granted Orphan Drug 68 Dividend Yield Outperforms 68 Improves Customer Experience 68 Launches Redesigned 68 Deliver Integrated 68 KEYWORD TELECOMMUNICATIONS 68 lead molecular radiotherapeutic 68 Demonstrates Positive 68 Delivers Solid 68 Lowers Price 68 Expand Into 68 Identifies Potential 68 Q3 Profit Rises 68 Receives Delisting Notification 68 Commenced Against 68 Announce Successful Completion 68 Commercialize Novel 68 Boosts Buyback 68 visit http:/www.PAREXEL.com 68 Downtrend Spotted 68 Signs Definitive Agreements 68 commercializing Loramyc ® 68 Presents Preclinical 68 Sells Shares 68 For Undisclosed Terms 68 Reduces Workforce 68 Lockheed Martin Ingersoll Rand 68 Provides Comprehensive 68 Improves Customer 68 Receives Accolades 68 Announces Expiration 68 Trend Continues Down 68 CALL VOLUME UP 68 Boosts Guidance 68 Awarded Contract 68 Marks Milestone 68 Cuts Costs 68 TECHNOLOGIES ANNOUNCES 68 Demonstrates Latest 68 Wins Coveted 68 Forges Ahead 68 Delivers Unparalleled 68 THE TREND CONTINUES DOWN 68 Extends Offer 68 NASDAQ CRTX 68 Reaches Milestone 68 Guides Above 68 ® DOUBLEMINT ® 68 Announces Repurchase 68 Finalizes Deal 68 Exceeds Guidance 68 Announce Commencement 68 NYSE Amex BTX 68 Revises Fourth Quarter 68 FDA Okays 68 Inc. LATEST NEWS 68 Offers Affordable 68 Empowers Consumers 68 Launches Website 68 Suspends Quarterly Dividend 68 Subsidiary Awarded Contract 68 Collaborators Present